Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history
- PMID: 20577641
- PMCID: PMC2890154
- DOI: 10.3389/fnagi.2010.00022
Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history
Abstract
The neurofibrillary degeneration that occurs in Alzheimer's disease (AD) is thought to be the result of a chronic and damaging neuroinflammatory response mediated by neurotoxic substances produced by activated microglial cells. This neuroinflammation hypothesis of AD pathogenesis has led to numerous clinical trials with anti-inflammatory drugs, none of which have shown clear benefits for slowing or preventing disease onset and progression. In this paper, I make the point that AD is not an inflammatory condition, and reconstruct the sequence of events during the 1980s and 1990s that I believe led to the development of this faulty theory.
Keywords: aging; amyloid; chronic inflammation; cytokines; major histocompatibility complex antigens.
References
-
- Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., Cooper N. R., Eikelenboom P., Emmerling M., Fiebich B. L., Finch C. E., Frautschy S., Griffin W. S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I. R., McGeer P. L., O'Banion M. K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F. L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383–42110.1016/S0197-4580(00)00124-X - DOI - PMC - PubMed
-
- Chao C. C., Hu S., Molitor T. W., Shaskan E. G., Peterson P. K. (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736–2741 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
